IRP
GILD icon

Investment Research Partners’s Gilead Sciences GILD Stock Holding History

Investment Research Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Sell
5,467
-658
-11% -$86.7K 0.23% 99
2026
Q1 		$854K Sell
6,125
-1,459
-19% -$204K 0.35% 71
2025
Q4 		$931K Sell
7,584
-249
-3% -$30.3K 0.4% 58
2025
Q3 		$928K Buy
+7,833
New +$890K 0.42% 57

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Investment Research Partners's GILD Position: Q2 2026 in Review

Investment Research Partners reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $86.7K and leaving 5,467 shares worth $691K. The position accounts for 0.23% of the portfolio, ranked #99.

Investment Research Partners first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $931K in Q4 2025. 1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Investment Research Partners held 5,467 shares of Gilead Sciences worth $691K as of Q2 2026.
  • Investment Research Partners sold 658 Gilead Sciences shares in Q2 2026, an estimated $86.7K.
  • Gilead Sciences made up 0.23% of Investment Research Partners's portfolio in Q2 2026, its #99 holding.
  • Investment Research Partners first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Investment Research Partners's Gilead Sciences position peaked at $931K in Q4 2025.
  • 1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.